This is surprising when, at least in the case of chronic pain patients, Weperen says a lot of money could be saved by the NHS.
Mr van Weperen explained: “These patients on average cost the NHS £15,000 per year each and that includes medication, consultation, doctor visits, pain clinics, A&E submissions etc.
“If you were to review those patients and see what you could do with reducing those opioids and replacing that with cannabis, we could probably take care of a lot of those patients for half the money.”
As a result, medicinal cannabis could play a role in helping the NHS in a post-COVID restriction environment as a way to help the government save money through more effective treatments for those with chronic pain.
Source: | This article first appeared on Express.co.uk